Dog Meds for Cushing's Disease: Complete Treatment & Cost Guide
Explore dog meds for Cushing's disease including trilostane, mitotane, dosages, costs, side effects, and what to expect from diagnosis through long-term management.
Cushing's disease — medically known as hyperadrenocorticism (HAC) — occurs when a dog's body produces excessive cortisol, a steroid hormone involved in stress response, metabolism, and immune function. It affects an estimated 1 to 2 out of every 1,000 dogs annually, making it one of the most common endocrine disorders in middle-aged and older dogs. The condition is typically caused by either a benign pituitary tumor (pituitary-dependent Cushing's, or PDH, accounting for roughly 80–85% of cases) or an adrenal gland tumor (adrenal-dependent Cushing's, or ADH, making up the remaining 15–20%). A third form, iatrogenic Cushing's, results from prolonged administration of corticosteroid medications.
Managing this condition almost always requires prescription medication, and understanding the options, costs, and long-term commitments involved will help you partner effectively with your veterinarian. This guide covers the primary dog meds for Cushing's disease, what diagnosis entails, realistic prognosis data, and the day-to-day management you can expect.
Recognizing Cushing's Disease: Symptoms by Severity
Cushing's disease develops gradually, which means early signs are easy to dismiss as normal aging. Organizing symptoms by severity can help you identify when to schedule a veterinary appointment versus when to seek urgent care.
| Severity | Symptoms | Notes |
|---|---|---|
| Early Warning Signs | Increased thirst (polydipsia) | Dog drinks noticeably more water; bowls emptied faster |
| Increased urination (polyuria) | More frequent outdoor breaks; possible house accidents in previously house-trained dogs | |
| Increased appetite (polyphagia) | Food-motivated behavior intensifies; begging, counter-surfing | |
| Mild panting increase | Panting more than usual at rest or in cool environments | |
| Moderate / Progressive | Pot-bellied appearance | Abdominal distension from weakened abdominal muscles and fat redistribution |
| Bilateral hair loss (alopecia) | Symmetric thinning on flanks, trunk; head and legs usually spared | |
| Thin, fragile skin | Skin tears easily; slow wound healing; visible blood vessels | |
| Muscle wasting | Especially in hindquarters; dog may appear weak or reluctant to jump | |
| Recurrent skin or ear infections | Immune suppression from excess cortisol | |
| Darkened skin patches (hyperpigmentation) | Often on abdomen and inner thighs | |
| Advanced / Severe | Calcium deposits in skin (calcinosis cutis) | Hard, gritty plaques; often on back, neck, or groin |
| Neurological signs (pituitary macroadenoma) | Disorientation, circling, seizures, vision changes — occurs in ~10–12% of PDH cases when tumor grows large | |
| Diabetes mellitus (comorbidity) | Excess cortisol induces insulin resistance | |
| Recurrent urinary tract infections | Steroid-induced immune suppression; may be asymptomatic | |
| Hypertension | Elevated blood pressure; risk of retinal damage and kidney stress | |
| Pulmonary thromboembolism | Blood clots in lungs — life-threatening emergency |
If your dog displays multiple early warning signs, schedule a veterinary appointment within 1–2 weeks. Advanced symptoms — particularly neurological changes, sudden collapse, or labored breathing — require emergency veterinary care immediately.
Breed Predisposition and Risk Factors
- Age: Most commonly diagnosed in dogs aged 7–12 years; rare under age 5
- Sex: Females are slightly more predisposed (approximately 60% of cases in some studies)
- Size: Pituitary-dependent Cushing's is more common in small to medium breeds; adrenal tumors appear more frequently in larger breeds
- Weight: Obesity is not a direct cause but can complicate diagnosis and management
- Prior corticosteroid use: Long-term prednisone, dexamethasone, or other steroid therapy can trigger iatrogenic Cushing's
While any dog can develop Cushing's disease, certain breeds show higher prevalence in veterinary literature. According to data referenced by the American Kennel Club, breeds with increased predisposition include:
- Poodles (especially Miniature and Toy) — among the highest risk breeds
- Dachshunds
- Small Terriers (Yorkshire, Boston, Cairn)
- Beagles
- German Shepherds — higher risk for adrenal-dependent form
- Golden Retrievers — also overrepresented for adrenal tumors
- Boxers
- Cocker Spaniels
Owning a predisposed breed doesn't mean your dog will develop Cushing's, but it does warrant closer attention to the early symptoms listed above as your dog enters their senior years.
How Veterinarians Diagnose Cushing's Disease
Diagnosing Cushing's disease is not a single-test event. Your veterinarian will follow a staged diagnostic process, and understanding each step helps you anticipate costs and timelines. According to the Merck Veterinary Manual, the diagnostic workup typically proceeds as follows:
- Clinical Suspicion: Based on symptoms, breed, age, and physical exam findings
- Baseline Blood Work & Urinalysis: Complete blood count (CBC), serum chemistry panel, and urinalysis — looking for elevated ALP (alkaline phosphatase), elevated cholesterol, dilute urine, possible UTI. Cost: $150–$300
- Screening Test — Low-Dose Dexamethasone Suppression Test (LDDST): Blood is drawn, a small dose of dexamethasone is injected, and blood is re-drawn at 4 and 8 hours. Failure to suppress cortisol confirms Cushing's. Cost: $200–$350
- Alternative Screening — ACTH Stimulation Test: Measures adrenal reserve; less sensitive for PDH (~60–65% sensitivity) but useful for iatrogenic Cushing's and adrenal tumors. Cost: $180–$300
- Differentiating Test — High-Dose Dexamethasone Suppression Test (HDDST): Helps distinguish PDH from ADH; approximately 70–75% of PDH dogs suppress on this test. Cost: $200–$350
- Endogenous ACTH Level: Blood test measuring ACTH concentration; high/normal suggests PDH, low suggests ADH. Cost: $120–$200
- Abdominal Ultrasound: Evaluates adrenal gland size and shape; bilaterally enlarged suggests PDH, one enlarged with one atrophied suggests ADH; can also detect adrenal tumors. Cost: $300–$600
- Advanced Imaging (if neurological signs present): MRI or CT of the brain to evaluate pituitary macroadenoma. Cost: $1,500–$3,000+
Total diagnostic costs for a straightforward case typically range from $500 to $1,500. Complex cases requiring advanced imaging or referral to a veterinary internist can push costs to $2,500–$4,500.
Note: Your veterinarian will determine which tests are appropriate for your individual dog. Not every dog needs every test in the sequence above.
Dog Meds for Cushing's Disease: Treatment Options Compared
Once Cushing's disease is confirmed and typed (pituitary-dependent vs. adrenal-dependent), treatment begins. The primary dog meds for Cushing's disease are trilostane and mitotane, with surgical options available for select cases. Here is a detailed comparison:
| Attribute | Trilostane (Vetoryl®) | Mitotane (Lysodren®) | Adrenalectomy (Surgery) |
|---|---|---|---|
| FDA Approval | FDA-approved for dogs (2008) | Human drug used off-label in dogs | N/A — surgical procedure |
| Mechanism | Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis | Selectively destroys adrenal cortex cells | Physical removal of adrenal tumor |
| Best For | PDH and ADH (non-surgical candidates) | PDH; less commonly used now | ADH with localized, non-metastatic tumor |
| Dosing | Once or twice daily with food; starting dose ~1–3 mg/kg (vet-determined) | Induction phase (daily for 5–10 days), then maintenance (1–2x/week) | Single procedure; may require short-term post-op supplementation |
| Effectiveness | ~75–85% of dogs show clinical improvement within 2–4 weeks | ~70–80% response rate; narrower therapeutic window | Curative in ~75–90% of benign ADH cases |
| Common Side Effects | Lethargy, decreased appetite, vomiting, diarrhea | Lethargy, vomiting, weakness, anorexia; risk of Addisonian crisis | Surgical risks: hemorrhage, pancreatitis, infection |
| Serious Risks | Addisonian crisis (rare but possible); adrenal necrosis (very rare) | Addisonian crisis (higher risk than trilostane); permanent hypoadrenocorticism | Mortality rate ~2–5% perioperative |
| Monitoring Required | ACTH stim test at 10–14 days, 30 days, 90 days, then every 3–6 months | ACTH stim test during induction, then periodically | Post-op monitoring; possible long-term if bilateral adrenalectomy |
| Monthly Cost (2026 estimate) | $40–$150 depending on dog size and dose | $25–$80 depending on dose and size | $1,500–$4,000 upfront; lower long-term if curative |
| Availability | Widely available; generic trilostane also available | Available through compounding pharmacies and human drug suppliers | Requires board-certified veterinary surgeon |
Trilostane (Vetoryl®): The Current First-Line Medication
Trilostane is the most commonly prescribed dog med for Cushing's disease in 2026 and is considered the first-line treatment by most veterinary endocrinologists. Brand-name Vetoryl® is manufactured by Dechra Veterinary Products, and generic trilostane capsules have become increasingly available, helping reduce costs for owners.
Trilostane works by inhibiting the enzyme 3β-hydroxysteroid dehydrogenase in the adrenal glands, which reduces cortisol production without destroying adrenal tissue. This reversible mechanism is a key reason it has largely replaced mitotane — if side effects occur, stopping the medication allows adrenal function to recover.
Critical: Trilostane must always be given with food to improve absorption. Your veterinarian will determine the exact dosage based on your dog's weight and ACTH stimulation test results. Never adjust the dose without veterinary guidance.
Mitotane (Lysodren®): The Older Alternative
Mitotane (o,p'-DDD) was the standard treatment for decades before trilostane's approval. It works by selectively destroying the zona fasciculata and zona reticularis layers of the adrenal cortex. While effective, its mechanism is irreversible — overdosing can cause permanent adrenal destruction and iatrogenic Addison's disease.
Some veterinarians still prefer mitotane for specific cases, and its lower drug cost makes it an option for budget-conscious owners. However, the higher risk of serious side effects means it requires more careful titration during the induction phase. Owners must watch for signs of an Addisonian crisis (severe lethargy, vomiting, collapse) and have a prednisone emergency protocol in place.
Surgical Options
For adrenal-dependent Cushing's disease caused by a single, non-metastatic adrenal tumor, surgical removal (adrenalectomy) can be curative. This procedure requires a board-certified veterinary surgeon and carries a perioperative mortality risk of approximately 2–5%. Dogs with malignant adrenal tumors (adrenal carcinomas) may not be surgical candidates if metastasis has occurred.
For pituitary-dependent Cushing's, transsphenoidal hypophysectomy (surgical removal of the pituitary tumor) is performed at a limited number of specialized veterinary centers, primarily at university teaching hospitals. This is a highly specialized procedure with limited availability in the U.S.
Radiation Therapy
When a pituitary macroadenoma causes neurological signs, radiation therapy may be recommended to shrink the tumor. Stereotactic radiosurgery (SRS) or conventional fractionated radiation can improve neurological symptoms in many cases, though it does not resolve the hormonal excess — medication is still needed to manage cortisol levels. Cost ranges from $3,000 to $6,000 depending on the facility and protocol.
Prognosis and Life Expectancy
Cushing's disease is generally manageable but not curable in most cases (pituitary-dependent). Understanding realistic outcomes helps set expectations:
| Scenario | Median Survival Time | Notes |
|---|---|---|
| PDH — well-managed with trilostane | 2–2.5 years (many live 3–5+ years) | Most common scenario; quality of life typically excellent with consistent treatment |
| PDH — untreated | Variable; months to ~2 years | Progressive complications: infections, diabetes, hypertension, thromboembolism |
| PDH with macroadenoma | ~1–2 years with treatment | Prognosis depends on tumor growth rate and neurological involvement |
| ADH — benign tumor, surgically removed | Often normal life expectancy | Curative if completely excised; recurrence possible but uncommon |
| ADH — malignant (adrenal carcinoma) | ~12–18 months | Metastasis common; surgery + adjunctive therapy may extend survival |
| Iatrogenic Cushing's | Normal if steroids tapered properly | Gradual steroid withdrawal under veterinary supervision; adrenal function typically recovers over weeks to months |
These are median values — individual dogs vary considerably. Many dogs with well-managed pituitary-dependent Cushing's live well beyond median survival times, especially when diagnosed early and monitored consistently. Your veterinarian can provide a more specific prognosis based on your dog's test results and overall health.
Home Care and Daily Management
Once your dog begins medication, your role as the caregiver becomes central to successful management. Here is what daily and long-term care involves:
Daily Responsibilities
- Administer medication consistently: Give trilostane at the same time(s) each day, always with food. Use a pill organizer or phone alarm to prevent missed doses.
- Monitor water intake: Track how much your dog drinks daily. A decrease in thirst is one of the first signs the medication is working — this typically occurs within 1–3 weeks.
- Watch for appetite changes: Reduced ravenous hunger is expected with treatment. However, sudden appetite loss (anorexia) is a red flag — contact your vet.
- Observe energy levels: Mild lethargy in the first week of treatment can be normal. Severe lethargy, weakness, or collapse requires immediate veterinary attention.
Monitoring Schedule
- 10–14 days after starting trilostane: First ACTH stimulation test to assess cortisol suppression
- 30 days: Second ACTH stim test; dose adjustment if needed
- 90 days: Third ACTH stim test; if stable, monitoring intervals extend
- Every 3–6 months thereafter: Ongoing ACTH stim tests, blood pressure checks, and chemistry panels for the life of the dog
Lifestyle Adjustments
- Consistent access to water: Even as treatment reduces excessive thirst, never restrict water access.
- More frequent potty breaks: During the initial treatment period, increased urination may persist.
- Skin and coat care: Hair regrowth is slow — expect 3–6 months before noticeable improvement. Use gentle, hypoallergenic shampoos. Address any secondary skin infections promptly.
- Weight management: As cortisol normalizes, metabolism shifts. Work with your vet to adjust caloric intake to prevent obesity.
- Emergency prednisone on hand: If your dog is on mitotane, your vet will prescribe emergency prednisone to counteract an Addisonian crisis. Keep it accessible at all times, including during travel.
Contact your veterinarian or an emergency clinic right away if your dog on Cushing's medication shows any of the following:
- Severe lethargy or inability to stand
- Persistent vomiting (more than 2 episodes in 24 hours)
- Complete loss of appetite lasting more than 24 hours
- Diarrhea with blood or dark/tarry stools
- Seizures, disorientation, or circling behavior
- Labored breathing or sudden collapse
- Signs of an Addisonian crisis: profound weakness, pale gums, low body temperature, shaking
These symptoms can indicate medication overdose, adrenal insufficiency, or disease complications requiring urgent intervention.
ASPCA Animal Poison Control: (888) 426-4435 (24/7, consultation fee applies) — call if your dog accidentally ingests a double dose or consumes medication not prescribed to them.
The Real Cost of Cushing's Disease Treatment
Budgeting for Cushing's disease requires understanding both upfront diagnostic costs and ongoing management expenses. Here is a realistic breakdown based on 2026 U.S. veterinary pricing:
| Expense Category | Cost Range (USD) | Frequency |
|---|---|---|
| Initial diagnostic workup (blood work, LDDST, urinalysis) | $500 – $1,500 | One-time |
| Abdominal ultrasound | $300 – $600 | One-time (may repeat annually) |
| Advanced imaging (MRI/CT for macroadenoma) | $1,500 – $3,000 | One-time (if indicated) |
| Trilostane medication (monthly) | $40 – $150 | Monthly, ongoing |
| Mitotane medication (monthly) | $25 – $80 | Monthly, ongoing |
| ACTH stimulation test (monitoring) | $150 – $300 | Every 3–6 months |
| Blood chemistry panel (monitoring) | $80 – $180 | Every 3–6 months |
| Blood pressure monitoring | $30 – $60 | Every 3–6 months |
| Adrenalectomy surgery (if applicable) | $1,500 – $4,000 | One-time |
| Radiation therapy (if applicable) | $3,000 – $6,000 | One-time course |
First-year total estimate: $1,500 – $4,000+ (including diagnosis and initial treatment stabilization)
Ongoing annual cost: $1,000 – $3,000+ (medication, monitoring tests, veterinary visits)
Worst-case scenarios involving macroadenoma treatment, emergency hospitalization for Addisonian crisis, or management of comorbidities like diabetes can push total costs significantly higher. Pet insurance that covers pre-existing condition exclusions may help offset some costs — review your policy carefully, as many insurers exclude Cushing's if symptoms appeared before enrollment.
Can Cushing's Disease Be Prevented?
Unfortunately, the most common forms of Cushing's disease — pituitary-dependent and adrenal-dependent — are not preventable. These arise from spontaneous tumors with no known lifestyle or environmental trigger that owners can control.
The one form that is preventable is iatrogenic Cushing's disease, which results from prolonged corticosteroid use. Strategies to reduce this risk include:
- Use steroids only when necessary: Work with your vet to explore non-steroidal alternatives for allergies, inflammation, and immune conditions (e.g., oclacitinib/Apoquel®, cyclosporine/Atopica®, lokivetmab/Cytopoint®).
- Lowest effective dose: If steroids are required, use the minimum dose for the shortest duration.
- Alternate-day dosing: When long-term steroid use is unavoidable, alternate-day protocols reduce adrenal suppression.
- Regular monitoring: Dogs on chronic steroids should have periodic blood work to catch early signs of iatrogenic Cushing's.
Frequently Asked Questions About Cushing's Disease Medications
What is the best dog med for Cushing's disease?
Trilostane (Vetoryl®) is the current first-line medication for most dogs with Cushing's disease due to its FDA approval for canine use, favorable safety profile, and reversible mechanism of action. However, the "best" medication depends on your dog's specific type of Cushing's, overall health, comorbidities, and your budget. Your veterinarian will make a tailored recommendation.
Can Cushing's disease be cured?
In most cases (pituitary-dependent), Cushing's disease is managed, not cured. Dogs require lifelong medication and monitoring. Adrenal-dependent Cushing's caused by a benign tumor can sometimes be cured through surgical removal. Iatrogenic Cushing's resolves when the causative steroid medication is gradually tapered under veterinary supervision.
How quickly will my dog improve after starting medication?
Most owners notice decreased drinking and urination within 1–3 weeks of starting trilostane. Appetite normalization may take 2–4 weeks. Hair regrowth and skin improvement are slower — expect 3–6 months for visible changes. Muscle tone and abdominal distension may improve over 2–4 months.
What happens if I miss a dose of trilostane?
Missing a single dose is unlikely to cause significant problems, as Cushing's disease develops over months and cortisol levels won't spike dramatically in 24 hours. Give the next dose at the regular scheduled time — do not double the dose. If you miss multiple consecutive doses, contact your veterinarian for guidance.
Are there natural or holistic alternatives to Cushing's medications?
There is no peer-reviewed evidence that supplements, herbs, or dietary changes can effectively treat Cushing's disease. Products marketed as "natural Cushing's remedies" (such as melatonin, lignans, or various herbal blends) may be used by some owners as supportive supplements, but they should never replace prescribed medication. Discuss any supplement with your veterinarian before adding it to your dog's regimen, as some can interact with trilostane or mitotane.
How long can a dog live with Cushing's disease?
With proper treatment and consistent monitoring, many dogs with pituitary-dependent Cushing's disease live 2–5 years or more after diagnosis, with good quality of life throughout. Dogs with benign adrenal tumors that are surgically removed may have a normal remaining lifespan. Untreated Cushing's disease progressively worsens and can lead to serious complications including diabetes, hypertension, thromboembolism, and organ damage.
Which breeds are most prone to Cushing's disease?
Breeds with documented higher risk include Poodles (especially Miniature and Toy), Dachshunds, small Terriers (Yorkshire, Boston, Cairn), Beagles, Boxers, and Cocker Spaniels for pituitary-dependent Cushing's. German Shepherds and Golden Retrievers show higher rates of the adrenal-dependent form. However, any breed can be affected, particularly in the 7–12 age range.
This article is for informational purposes only and does not replace professional veterinary advice. Always consult your veterinarian for diagnosis, treatment decisions, and medication management for your dog's specific condition.
Priya Sutaria
All our authors care for dogs every day — read more of their work on the authors page.
